Atara Biotherapeutics Long Term Debt Current 2011-2026 | ATRA

Annual Long Term Debt Current Atara Biotherapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.03 M	12.9 M	11.3 M	12.8 M	2.58 M	1.73 M	1.31 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
12.9 M	1.03 M	6.23 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	213 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	271 K	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	3.08 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	48 K	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	8.06 M	-	-	$ 866 M	China
Ascendis Pharma A/S ASND	14.2 M	$ 221.14	2.6 %	$ 5 B	Danmark
Aptinyx APTX	337 K	-	-39.0 %	$ 4.57 M	USA
Processa Pharmaceuticals PCSA	83.6 K	$ 2.37	1.72 %	$ 3.1 M	USA
Amphastar Pharmaceuticals AMPH	7.93 M	$ 19.6	1.92 %	$ 916 M	USA
Applied Genetic Technologies Corporation AGTC	1.27 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	419 K	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	428 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	1.59 M	-	-24.86 %	$ 820 K	USA
Atreca BCEL	3.54 M	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	75 K	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	20.7 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	21.2 M	-	-	$ 546 M	USA
Cara Therapeutics CARA	1.92 M	-	-3.03 %	$ 260 M	USA
Phathom Pharmaceuticals PHAT	648 K	$ 10.35	2.88 %	$ 755 M	USA
Adverum Biotechnologies ADVM	5.67 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	104 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	166 K	-	-9.65 %	$ 45.9 M	USA
Phio Pharmaceuticals Corp. PHIO	35 K	$ 1.27	4.09 %	$ 7.6 M	USA
Autolus Therapeutics plc AUTL	5.05 M	$ 1.35	1.89 %	$ 344 M	Britain
Corbus Pharmaceuticals Holdings CRBP	1.63 M	$ 8.23	0.61 %	$ 110 M	USA
CRISPR Therapeutics AG CRSP	18.6 M	$ 47.4	2.09 %	$ 4.26 B	Schweiz
ChemoCentryx CCXI	2.81 M	-	-	$ 3.74 B	USA
Pliant Therapeutics PLRX	1.45 M	$ 1.32	3.13 %	$ 81 M	USA
PMV Pharmaceuticals PMVP	403 K	$ 1.39	-0.36 %	$ 73 M	USA
Dynavax Technologies Corporation DVAX	4.18 M	-	-	$ 2.02 B	USA
Enochian Biosciences ENOB	313 K	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	3.47 M	-	-	$ 867 M	Germany
Bellerophon Therapeutics BLPH	203 K	-	-74.18 %	$ 955 K	USA
Prelude Therapeutics Incorporated PRLD	2.74 M	$ 3.26	4.49 %	$ 251 M	USA
ProQR Therapeutics N.V. PRQR	1.54 M	$ 1.53	2.35 %	$ 99.5 M	Niderland
Arbutus Biopharma Corporation ABUS	547 K	$ 4.51	4.76 %	$ 864 M	Canada
Homology Medicines FIXX	693 K	-	0.77 %	$ 53.4 M	USA
Akouos AKUS	671 K	-	0.23 %	$ 488 M	USA